About Lilly EU

Welcome to Lilly EU.

Lilly has a heritage of more than 145 years, with headquarters located in Indianapolis, USA. Established in Europe in 1934, our commercial activities span across the continent.

Lilly has a long track record of remarkable advances in the fight against disease. Our medical innovation is focused on some of the most significant unmet patient needs both globally and in Europe—in the areas of diabetes, oncology, immunology, and neurodegeneration.

Lilly has a considerable R&D and manufacturing presence located across five sites in Europe: Alcobendas, Spain (since 1968); Fegersheim, France (since 1967); Kinsale (since 1981) and Limerick (since 2022), Ireland ; Sesto Fiorentino, Italy (since 1959) and Alzey, Germany (since 2023). With operations throughout Europe, Lilly has a strong European footprint and is committed to working with all stakeholders to build a healthier Europe.

This site is dedicated to public policy issues, corporate responsibility initiatives, and the work our employees do every day to make life better for people who depend on us.

Thank you for your visit.

Marcel Lechanteur

President, Lilly France, Benelux and EU Affairs